The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 156K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rebel, V. I.
Right arrow Articles by Sieff, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rebel, V. I.
Right arrow Articles by Sieff, C. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1999/11/1493/ $5.00
The Journal of Experimental Medicine, Volume 190, Number 10, November 15, 1999 1493-1504


Original Article

Essential Role for the P55 Tumor Necrosis Factor Receptor in Regulating Hematopoiesis at a Stem Cell Level

Vivienne I. Rebela,b, Sheila Hartnetta,b, Geoffrey R. Hilla,b, Suzan B. Lazo-Kallanianc, James L.M. Ferraraa,b, and Colin A. Sieffa,b

a Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115
b Department of Hematology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115
c Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115
Dana-Farber Cancer Institute, Rm. M613, 44 Binney St., Boston, MA 02115.617-632-5757617-632-2070

vivienne_rebel{at}dfci.harvard.edu

Hematopoietic stem cell (HSC) self-renewal is a complicated process, and its regulatory mechanisms are poorly understood. Previous studies have identified tumor necrosis factor (TNF)-{alpha} as a pleiotropic cytokine, which, among other actions, prevents various hematopoietic progenitor cells from proliferating and differentiating in vitro. However, its role in regulating long-term repopulating HSCs in vivo has not been investigated. In this study, mice deficient for the p55 or the p75 subunit of the TNF receptor were analyzed in a variety of hematopoietic progenitor and stem cell assays. In older p55–/– mice (>6 mo), we identified significant differences in their hematopoietic system compared with age-matched p75–/– or wild-type counterparts. Increased marrow cellularity and increased numbers of myeloid and erythroid colony-forming progenitor cells (CFCs), paralleled by elevated peripheral blood cell counts, were found in p55-deficient mice. In contrast to the increased myeloid compartment, pre-B CFCs were deficient in older p55–/– mice. In addition, a fourfold decrease in the number of HSCs could be demonstrated in a competitive repopulating assay. Secondary transplantations of marrow cells from primary recipients of p55–/– marrow revealed impaired self-renewal ability of p55-deficient HSCs. These data show that, in vivo, signaling through the p55 subunit of the TNF receptor is essential for regulating hematopoiesis at the stem cell level.

Key Words: hematopoietic stem cell • cell differentiation • cytokine receptors


G.R. Hill's present address is Mater Medical Research Institute, South Brisbane QLD 4101, Australia; J.L.M. Ferrara's present address is Departments of Internal Medicine and Pediatrics, Division of Hematology and Oncology, University of Michigan Cancer Center, Ann Arbor, MI 48109.

Abbreviations used in this paper: BFU-E, erythroid burst-forming unit; BM, bone marrow; CFC, colony-forming cell; CFU-GEMM, multilineage CFU; CFU-G/M, granulocyte/macrophage CFU; CFU-S, CFU in the spleen; CRU, competitive repopulating unit(s); HSC, hematopoietic stem cell; Lin, lineage; PB, peripheral blood; PI, propidium iodide; SSC, side scatter; WBC, white blood cell; WT, wild-type.

J.L.M. Ferrara and C.A. Sieff contributed equally to this paper.

© 1999 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS